Clinical Trial Update: Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device [NA]

View source ↗

Summary

FluxWear, INC is enrolling by invitation in a clinical study of a low-intensity cranial PEMF device to help manage chemotherapy-induced peripheral neuropathy in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• FluxWear Cranial PEMF Device

Snippet

Sponsor: FluxWear, INC | Conditions: Chemotherapy Induced Peripheral Neuropathy, Chemotherapy Induced Peripheral Neuropathy (CIPN) | NA | Status: ENROLLING_BY_INVITATION